期刊文献+

无肝状态下丙泊酚代谢相关UGT1A6在大鼠肝外器官的基因表达

Expression of Extrahepatic Gene of Propofol Metabolism-Related UGT1A6 in Anhepatic Phase
原文传递
导出
摘要 目的:研究无肝期前、后与丙泊酚代谢相关的代谢酶UGT1A6在大鼠小肠、肾、肺、脑器官组织中基因表达的变化,以期初步阐释丙泊酚无肝期肝外代谢特点形成的原因。方法:15只大鼠单次注射丙泊酚后随机分为3组(n=5),A组为对照组,B组阻断肝门30min,C组阻断肝门60min,截取各组大鼠小肠、肾、肺、脑器官组织,采用逆转录聚合酶链式反应(RT-PCR)技术,检测各组UGT1A6mRNA的表达。结果:大鼠各受检器官组织中UGT1A6的基因表达水平B、C组明显高于A组(P<0.01);B组与C组相比,没有显著性差异(P>0.05)。结论:大鼠受检组织中UGT1A6基因表达在无肝期比无肝期前增多,系可能促进丙泊酚无肝期肝外代谢增强的原因。 OBJECTIVE:To study the variation of gene expression of propofol metabolism- related UGT1A6 in small intestine, kindney, lung and brain of rats before and after anhepatic phase so as to reveal the mechanism of extrahepatic metabolism characters of propofol. METHODS: 15 rats were divided into 3 groups after injection of single dose of propofol (n = 5) : group A (control group), group B in which the hepatic portal was devascularized for 30min, and group C in which the hepatic portal was devascularized for 60 min. Small intestine, kindney, lung and brain tissues of rats were taken for the detection of UGT1A6 mRNA by RT - PCR techniques. RESULTS: Gene expression levels of UGT1A6 in small intestine, kindney, lung and brain in group B and group C were significantly higher than in group A(P〈0.01); The gene expression levels between B and C had no significant difference (P 〉0.05). CONCLUSION: Gene expression levels of extrahepatic UGT1A6 of rats are increased in anhepatic phase as compared with before anhepatic phase, which might be attributed to the enhancement of extrahepatic metabolism of propofol in anhepatic phase.
出处 《中国药房》 CAS CSCD 北大核心 2008年第7期498-500,共3页 China Pharmacy
基金 国家自然科学基金资助项目(30600585)
关键词 丙泊酚 UGT1A6 无肝期 基因表达 Propofol UGT1A6 Anhepatic phase Gene expression
  • 相关文献

参考文献8

  • 1Ethell BT, Skins S, Wang J, et al. Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and U GT1A9[J ], Drug Metab Dispos ,2002,30(6):734.
  • 2Shelby MK, Cherrington NJ, Vansell NR, Tissue mR NA expression of the rat UDP- glucuronosyltransfer ase gene family[J ] , Drug Metab Dispos , 2003,31(3) : 326.
  • 3朱益贫,杨立群,俞卫锋.小儿肝移植无肝期丙泊酚的药代动力学特点[J].第二军医大学学报,2001,22(9):875-877. 被引量:8
  • 4彭金咏,栾连军.尿苷二磷酸葡萄糖醛酸转移酶的研究进展[J].中国现代应用药学,2002,19(5):373-376. 被引量:11
  • 5李新.人体内的葡醛酸结合反应及其影响因素[J].中国临床药理学杂志,2002,18(5):387-395. 被引量:7
  • 6Krishnaswamy S, Hao Q, Al - Rohaimi A, et al. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5' -regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation[J ]. J Pharmacol Exp Ther ,2005,313(3) : 1 331.
  • 7Hiroshi Y, Yohko K, Yasuko S, et al. Effects on extrahepatic UDP glucuronosyltransferase in hypophy- sectomized rat [J ] .J Biochem , 2002,132(2) : 265.
  • 8Gueraud F, Daveloose D, Vezin H, et al. In vivo modification of the UDP- glucuronosyltransferase functional state in rat liver following hypophysectomy and partial or complete hormonanl restoration[J ] .J Biochem , 2003, 134(5) : 641.

二级参考文献45

  • 1贺平.有关安替比林代谢的临床药理研究[J].中国药理学通报,1996,21(4):306-309. 被引量:7
  • 2傅丽红,冉国侠,许伟彬,卡哈尔,逢全,焦士林,曹泽兵.异丙酚临床药物动力学研究[J].中国医院药学杂志,1997,17(2):51-53. 被引量:17
  • 3[23]McGurk KA, Brierley CH, Burchell B. Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol,1998;55:1005~1012
  • 4[24]Lampe JW, Bigler J, Bush AC, et al. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prey,2000; 9:329~333.
  • 5[25]Levesque E, Beaulieu M, Green MD, et al. Isolation and characterization of UGT2B 15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.Pharmacogenetics,1997; 7: 317~325.
  • 6[26]Belanger A, Hum DW, Beaulieu M, et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.J Steroid Biochem Mol Bio1,1998; 65: 301~310.
  • 7[27]Brown SY, Garland WA, Fukuda EK. Isolation and characterization of an unusual glucuronide conjugate of rimantadine. Drug Metab Dispos, 1990; 18: 546~547.
  • 8[28]Burchell B and Coughtrie MWH. UDP-glucuronosyltransferases.Pharm Ther, 1989:261~289.
  • 9[29]Bock KW, Gschaidmeier H, Heel H, et al. Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metabolism Reviews, 1999;31:411~422.
  • 10[30]Bock KW, Gschaidmeier H, Heel H, et al. AH receptor-controlled transcriptional regulation and function of rat and human UDPglucuronosyltransferase isoforms. Adv Enzyme Regul, 1998: 38207-38222.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部